XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock Series A Cumulative [Member]
Preferred Stock Series X [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 1 $ 795 $ 11,973,051 $ (2,219,091) $ 9,754,756
Beginning balance, shares at Dec. 31, 2020 2,000 7,945,034      
Settlement of stock in connection with prior acquisition (note 2) 21,420 21,420
Shares granted to settle previously recorded liability (in shares)     3,000        
Warrant liability recognized in connection with initial issuance of November offering (See Note 7) (135,125) (135,125)
Exercise of warrants $ 2 1,155 1,157
Exercise of warrants (in shares)     17,135        
Common stock issued for acquisition $ 137 7,122,363 7,122,500
Common stock issued for acquisition (in shares)     1,375,000        
Stock-based compensation $ 6 210,735 210,741
Stock-based compensation (in shares)     62,500        
Net Loss (1,032,951) (1,032,951)
Ending balance, value at Mar. 31, 2021 $ 1 $ 940 19,193,599 (3,252,042) 15,942,498
Ending balance, shares at Mar. 31, 2021 2,000 9,402,669      
Beginning balance, value at Dec. 31, 2020 $ 1 $ 795 11,973,051 (2,219,091) 9,754,756
Beginning balance, shares at Dec. 31, 2020 2,000 7,945,034      
Ending balance, value at Dec. 31, 2021 $ 55 $ 1 $ 1,278 42,877,622 (10,213,196) 32,665,760
Ending balance, shares at Dec. 31, 2021 552,000 2,000 12,775,674      
Beginning balance, value at Mar. 31, 2021 $ 1 $ 940 19,193,599 (3,252,042) 15,942,498
Beginning balance, shares at Mar. 31, 2021 2,000 9,402,669      
Exercise of warrants
Exercise of warrants (in shares)     717        
Stock-based compensation $ 2 465,598 465,600
Stock-based compensation (in shares)     12,000        
Net Loss (2,138,232) (2,138,232)
Ending balance, value at Jun. 30, 2021 $ 1 $ 942 19,659,197 (5,390,274) 14,269,866
Ending balance, shares at Jun. 30, 2021 2,000 9,415,386      
Beginning balance, value at Dec. 31, 2021 $ 55 $ 1 $ 1,278 42,877,622 (10,213,196) 32,665,760
Beginning balance, shares at Dec. 31, 2021 552,000 2,000 12,775,674      
Settlement of stock in connection with prior acquisition (note 2) $ (40) 40
Shares granted to settle previously recorded liability (in shares)     (400,000)        
Common stock issued in public offering (over-allotment), net of costs $ 40 1,091,960 1,092,000
Common stock issued in public offering, net of costs shares     400,000        
Stock-based compensation $ 11 287,988 287,999
Stock-based compensation (in shares)     112,500        
Dividends paid to preferred shareholders (362,250) (362,250)
Net Loss (1,649,872) (1,649,872)
Ending balance, value at Mar. 31, 2022 $ 55 $ 1 $ 1,289 44,257,610 (12,225,318) 32,033,637
Ending balance, shares at Mar. 31, 2022 552,000 2,000 12,888,174      
Beginning balance, value at Dec. 31, 2021 $ 55 $ 1 $ 1,278 42,877,622 (10,213,196) 32,665,760
Beginning balance, shares at Dec. 31, 2021 552,000 2,000 12,775,674      
Ending balance, value at Jun. 30, 2022 $ 55 $ 1 $ 1,294 $ (149,686) 44,370,056 (15,476,223) 28,745,497
Ending balance, shares at Jun. 30, 2022 552,000 2,000 12,930,674 113,485      
Beginning balance, value at Mar. 31, 2022 $ 55 $ 1 $ 1,289 44,257,610 (12,225,318) 32,033,637
Beginning balance, shares at Mar. 31, 2022 552,000 2,000 12,888,174      
Cancellation of restricted shares $ (5) 5
Cancellation of restricted shares, shares     (52,500)        
Stock-based compensation $ 10 112,441 112,451
Stock-based compensation (in shares)     95,000        
Treasury shares repurchased $ (149,686) (149,686)
Shares repurchased, shares     113,485      
Dividends paid to preferred shareholders (362,250) (362,250)
Net Loss (2,888,655) (2,888,655)
Ending balance, value at Jun. 30, 2022 $ 55 $ 1 $ 1,294 $ (149,686) $ 44,370,056 $ (15,476,223) $ 28,745,497
Ending balance, shares at Jun. 30, 2022 552,000 2,000 12,930,674 113,485